Executive teams
Strategic intelligence and fractional commercial support
For biotechs at Series A and beyond, Auxinia works cross-functionally across executive, commercial and R&D teams to provide actionable strategic intelligence to help guide a decision.
And sometimes, an extra pair of hands is needed to provide a read on a new indication or target, to monitor the competitive landscape for your pipeline, to cover a medical conference, or to provide BD support over partnering conferences.
Scenarios
Do you need support out-licensing a program?
Do you need boots on the ground at an upcoming medical conference?
Are you considering a pivot?
Do you need support keeping on top of competitor activities?
Do you have an important strategic question that needs answering?
The approach
Deep dive first
Flexible and bespoke
Responsibly supported by AI
Contact
Book a scoping call
Send a message
For biotechs at Series A and beyond, Auxinia works cross-functionally across executive, commercial and R&D teams to provide actionable strategic intelligence to help guide a decision.
And sometimes, an extra pair of hands is needed to provide a read on a new indication or target, to monitor the competitive landscape for your pipeline, to cover a medical conference, or to provide BD support over partnering conferences.
Scenarios
- Research to generate a list of leads with strategic rationale
- Support for preparing for a partnering conference, tailored outreach messages, meeting notes, and conference planning
- Review and update for partnering decks
- Coverage of strategically relevant sessions
- Coverage of landscape, trends and activities
- Discussions and feedback from KOLs and sponsors for key strategic questions
- Deep-dive and SWOT analysis
- Assessment of the commercial opportunity in a new therapeutic area
- rNPV inputs and assumptions for evaluating the impact to your valuation
- AI automated competitor monitoring
- Alerts for high-profile news
- Database of competitor history
- Competitor activity and status dashboard
- KOL identification, onboarding and interviews
- Deep-dive secondary intelligence gathering and analysis
- Primary research
The approach
Deep dive firstLong-term engagements start with in-depth foundational research. That is what makes the intelligence that follows specific to the nuances of your situation.
Flexible and bespokeCash-flow uncertainty is a common part of the biotech journey. Unlike a salary, retainers can be paused to cover periods of low funding. Ad-hoc projects bring in the expertise as and when you need it.
Responsibly supported by AIMany aspects of commercial intelligence can be enhanced by the thoughtful application of AI. Auxinia treats AI as a highly competent but untrustworthy intern bringing the benefit of experienced human oversight with machine efficiency.
Auxinia works on an anti-slop basis. Every claim is rigorously validated and sense-checked for accuracy and relevance.